203 related articles for article (PubMed ID: 26239291)
1. Nonmuscle myosin IIB as a therapeutic target for the prevention of relapse to methamphetamine use.
Young EJ; Blouin AM; Briggs SB; Sillivan SE; Lin L; Cameron MD; Rumbaugh G; Miller CA
Mol Psychiatry; 2016 May; 21(5):615-23. PubMed ID: 26239291
[TBL] [Abstract][Full Text] [Related]
2. Nonmuscle myosin II inhibition disrupts methamphetamine-associated memory in females and adolescents.
Young EJ; Briggs SB; Rumbaugh G; Miller CA
Neurobiol Learn Mem; 2017 Mar; 139():109-116. PubMed ID: 28082169
[TBL] [Abstract][Full Text] [Related]
3. The role of nonmuscle myosin II in polydrug memories and memory reconsolidation.
Briggs SB; Hafenbreidel M; Young EJ; Rumbaugh G; Miller CA
Learn Mem; 2018 Sep; 25(9):391-398. PubMed ID: 30115760
[TBL] [Abstract][Full Text] [Related]
4. Methamphetamine Learning Induces Persistent and Selective Nonmuscle Myosin II-Dependent Spine Motility in the Basolateral Amygdala.
Young EJ; Lin H; Kamenecka TM; Rumbaugh G; Miller CA
J Neurosci; 2020 Mar; 40(13):2695-2707. PubMed ID: 32066582
[TBL] [Abstract][Full Text] [Related]
5. Selective, retrieval-independent disruption of methamphetamine-associated memory by actin depolymerization.
Young EJ; Aceti M; Griggs EM; Fuchs RA; Zigmond Z; Rumbaugh G; Miller CA
Biol Psychiatry; 2014 Jan; 75(2):96-104. PubMed ID: 24012327
[TBL] [Abstract][Full Text] [Related]
6. The Actin Cytoskeleton as a Therapeutic Target for the Prevention of Relapse to Methamphetamine Use.
Young EJ; Briggs SB; Miller CA
CNS Neurol Disord Drug Targets; 2015; 14(6):731-7. PubMed ID: 26022262
[TBL] [Abstract][Full Text] [Related]
7. Myosin II motor activity in the lateral amygdala is required for fear memory consolidation.
Gavin CF; Rubio MD; Young E; Miller C; Rumbaugh G
Learn Mem; 2012 Jan; 19(1):9-14. PubMed ID: 22174310
[TBL] [Abstract][Full Text] [Related]
8. Basolateral amygdala corticotropin releasing factor receptor 2 interacts with nonmuscle myosin II to destabilize memory in males.
Hafenbreidel M; Pandey S; Briggs SB; Arza M; Bonthu S; Fisher C; Tiller A; Hall AB; Reed S; Mayorga N; Lin L; Khan S; Cameron MD; Rumbaugh G; Miller CA
Neurobiol Learn Mem; 2023 Dec; 206():107865. PubMed ID: 37995804
[TBL] [Abstract][Full Text] [Related]
9. Basolateral Amygdala Corticotrophin Releasing Factor Receptor 2 Interacts with Nonmuscle Myosin II to Destabilize Memory.
Hafenbreidel M; Briggs SB; Arza M; Bonthu S; Fisher C; Tiller A; Hall AB; Reed S; Mayorga N; Lin L; Khan S; Cameron MD; Rumbaugh G; Miller CA
bioRxiv; 2023 May; ():. PubMed ID: 37292925
[TBL] [Abstract][Full Text] [Related]
10. Memory disrupting effects of nonmuscle myosin II inhibition depend on the class of abused drug and brain region.
Briggs SB; Blouin AM; Young EJ; Rumbaugh G; Miller CA
Learn Mem; 2017 Feb; 24(2):70-75. PubMed ID: 28096495
[TBL] [Abstract][Full Text] [Related]
11. AMPA receptor endocytosis in the amygdala is involved in the disrupted reconsolidation of Methamphetamine-associated contextual memory.
Yu YJ; Chang CH; Gean PW
Neurobiol Learn Mem; 2013 Jul; 103():72-81. PubMed ID: 23603364
[TBL] [Abstract][Full Text] [Related]
12. Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes.
Zhang M; Rao PV
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4130-8. PubMed ID: 16249490
[TBL] [Abstract][Full Text] [Related]
13. Kinetic mechanism of blebbistatin inhibition of nonmuscle myosin IIb.
Ramamurthy B; Yengo CM; Straight AF; Mitchison TJ; Sweeney HL
Biochemistry; 2004 Nov; 43(46):14832-9. PubMed ID: 15544354
[TBL] [Abstract][Full Text] [Related]
14. Input-specific regulation of hippocampal circuit maturation by non-muscle myosin IIB.
Ozkan ED; Aceti M; Creson TK; Rojas CS; Hubbs CR; McGuire MN; Kakad PP; Miller CA; Rumbaugh G
J Neurochem; 2015 Aug; 134(3):429-44. PubMed ID: 25931194
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol inhibits priming-induced reinstatement of methamphetamine in REM sleep deprived rats.
Karimi-Haghighi S; Haghparast A
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Mar; 82():307-313. PubMed ID: 28870635
[TBL] [Abstract][Full Text] [Related]
16. Effects of a methamphetamine vaccine, IXT-v100, on methamphetamine-related behaviors.
Keller CM; Spence AL; Stevens MW; Owens SM; Guerin GF; Goeders NE
Psychopharmacology (Berl); 2020 Mar; 237(3):655-667. PubMed ID: 31758209
[TBL] [Abstract][Full Text] [Related]
17. Involvement of metabotropic glutamate receptor 5 in the inhibition of methamphetamine-associated contextual memory after prolonged extinction training.
Huang CH; Yu YJ; Chang CH; Gean PW
J Neurochem; 2016 Apr; 137(2):216-25. PubMed ID: 26748780
[TBL] [Abstract][Full Text] [Related]
18. Modafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse.
Reichel CM; See RE
Psychopharmacology (Berl); 2010 Jun; 210(3):337-46. PubMed ID: 20352413
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of vesicular glutamate transporters contributes to attenuate methamphetamine-induced conditioned place preference in rats.
He Z; Chen Y; Dong H; Su R; Gong Z; Yan L
Behav Brain Res; 2014 Jul; 267():1-5. PubMed ID: 24613241
[TBL] [Abstract][Full Text] [Related]
20. Memory of a drug lapse: Role of noradrenaline.
Cummins Jacklin E; Boughner E; Kent K; Kwiatkowski D; MacDonald T; Leri F
Neuropharmacology; 2015 Dec; 99():98-105. PubMed ID: 26192542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
